Patheon, Inc. is expanding its Manati, PR facility to add a dedicated high potency and controlled substance manufacturing area. The company will invest $2.8 million in a new 3,386-sq.-ft. area that will include three manufacturing suites, air lock containment areas, and humidity controlled air systems.     The three manufacturing suites will create one manufacturing area technology transfer, bulk production, bulk packaging, and storage. The production area will have capacity for high potency ...